The department “Synthesis of Macromolecules” develops tailored nanomaterials for biomedical and materials science applications. It also designs and synthesizes precision macromolecules and hybrid materials that can, for example, enhance the uptake of viruses into stem cells thus offering great opportunities to improve gene therapy.
The HYPERDIAMOND project was selected as one of the eight projects (out of 390) in the Horizon 2020 call Personalizing Health and Care: Development of new diagnostic tools and technologies. It is aiming at developing a new technology for improving medical imaging in vivo based on hyperpolarized diamond.
BIOQ will create novel sensing technologies for the broad field of life science research, providing unprecedented insight into the structure and function of individual bio-molecules under physiological conditions. Our ultimate goal is to develop hybrid materials of functionalized nanodiamonds that harness complex quantum dynamics at room temperature to observe biological processes down to the quantum level and with atomic resolution.
The consortium investigates the microbial involvement in the development of Alzheimer’s Disease (AD) with the aim of microbiome modulation to slow down or halt its onset. This paves the road to new indirect diagnostic and therapeutic approaches for AD prevention, based on gut microbiota modulation through delivery of probiotic cocktails.